Literature DB >> 17234903

Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.

Charles-Edouard Luyt1, Alain Combes, Claire Deback, Marie-Hélène Aubriot-Lorton, Ania Nieszkowska, Jean-Louis Trouillet, Frédérique Capron, Henri Agut, Claude Gibert, Jean Chastre.   

Abstract

RATIONALE: It is not known whether the isolation of herpes simplex virus (HSV) from lower respiratory tract samples of nonimmunocompromised ventilated patients corresponds to bronchial contamination from the mouth and/or throat, local tracheobronchial excretion of HSV, or true HSV lung involvement (bronchopneumonitis) with its own morbidity/mortality.
OBJECTIVES: This prospective, single-center, observational study was conducted to define the frequency, risk factors, and relevance of HSV bronchopneumonitis.
METHODS: All consecutive nonimmunocompromised patients receiving mechanical ventilation for 5 days or more were evaluated. Bronchoalveolar lavage, oropharyngeal swabs, and bronchial biopsies (presence of macroscopic bronchial lesions) were obtained for all who deteriorated clinically with suspected lung infection. HSV bronchopneumonitis was defined as this deterioration, associated with HSV in bronchoalveolar lavage and HSV-specific nuclear inclusions in cells recovered during lavage or bronchial biopsies.
MEASUREMENTS AND MAIN RESULTS: HSV bronchopneumonitis was diagnosed in 42 (21%) of the 201 patients who deteriorated clinically, with a mean mechanical ventilation duration before diagnosis of 14 +/- 6 days. Risk factors associated with HSV bronchopneumonitis were oral-labial lesions, HSV in the throat, and macroscopic bronchial lesions seen during bronchoscopy. Patients with HSV bronchopneumonitis were comparable to those without at admission, but their courses were more complicated, with longer duration of mechanical ventilation and intensive care unit stays.
CONCLUSIONS: HSV bronchopneumonitis is common in nonimmunocompromised patients with prolonged mechanical ventilation, is associated with HSV reactivation or infection of the mouth and/or throat, and seems to be associated with poorer outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17234903     DOI: 10.1164/rccm.200609-1322OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  111 in total

1.  Viral community-acquired pneumonia: if we do not diagnose it and do not treat it, can it still hurt us?

Authors:  Michael S Niederman
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

2.  Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis.

Authors:  Pavan Brahmamdam; Shigeaki Inoue; Jacqueline Unsinger; Katherine C Chang; Jonathan E McDunn; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2010-05-18       Impact factor: 4.962

Review 3.  Advances in the management of sepsis and the understanding of key immunologic defects.

Authors:  Lee P Skrupky; Paul W Kerby; Richard S Hotchkiss
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

4.  Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro.

Authors:  Jean-Marie Forel; Ignacio Martin-Loeches; Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2014-11-01       Impact factor: 17.440

Review 5.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

6.  Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients.

Authors:  Catharina F M Linssen; Jan A Jacobs; Foekje F Stelma; Walther N K A van Mook; Peter Terporten; Cornelis Vink; Marjolein Drent; Cathrien A Bruggeman; Annick Smismans
Journal:  Intensive Care Med       Date:  2008-08-05       Impact factor: 17.440

7.  Latent viral infections in critically ill patients.

Authors:  Matt P Wise; Paul J Frost; Chris D Hingston; Andrew J Godkin
Journal:  Crit Care       Date:  2009-06-17       Impact factor: 9.097

8.  CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study.

Authors:  Kevin L Lawrence; Patrick H White; Gerald P Morris; Jody Jennemann; Donna L Phelan; Richard S Hotchkiss; Marin H Kollef
Journal:  Crit Care       Date:  2010-06-11       Impact factor: 9.097

9.  Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease.

Authors:  Matthias N Witt; Gerald S Braun; Stephan Ihrler; Holger Schmid
Journal:  BMC Pulm Med       Date:  2009-05-18       Impact factor: 3.317

10.  Clinical course and spectrum of intensive care unit patients reactivating herpes simplex-1 virus: a retrospective analysis.

Authors:  Krishna M Sundar; Karl A Ludwig; William T Alward; Michael J Pearce; Clark T Bishop; Roy C Hammond; David R Hillyard; Steven W Freestone; Anne Ozment; Barbara C Cahill
Journal:  Indian J Crit Care Med       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.